婴幼儿眼部血管瘤治疗进展

doi:10.3760/cma.j.issn.1674-845X.2013.10.015

Abstract
Figure/Table
References (35)
Related Citation (9)

[1]	Kilcline C， Frieden IJ. Infantile hemangiomas： how common are they? A systematic review of the medical literature. Pediatr Dermatol，2008，25：168-173.
[2]	Dickison P， Christou E， Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol，2011，28：663-669.
[3]	Fay A， Nguyen J， Jakobiec FA， et al. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol，2010，128：256-258.
[4]	Dubois J， Milot J， Jaeger BI， et al. Orbit and eyelid hemangiomas： is there a relationship between location and ocular problems? J Am Acad Dermatol，2006，55：614-619.
[5]	Alniemi ST， Griepentrog GJ， Diehl N， et al. Rate of amblyopia in periocular infantile hemangiomas. Arch Ophthalmol，2012， 130：943-944.
[6]	Wasserman BN， Medow NB， Homa-Palladino M， et al. Treatment of periocular capillary hemangiomas. J AAPOS，2004， 8：175-181.
[7]	Weiss AH， Kelly JP. Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology，2008，115：390-397 e1.
[8]	Ranchod TM， Frieden IJ， Fredrick DR. Corticosteroid treatment of periorbital haemangioma of infancy： a review of the evidence. Br J Ophthalmol，2005，89：1134-1138.
[9]	Hayreh SS， Zimmerman MB. Central retinal artery occlusion： visual outcome. Am J Ophthalmol，2005，140：376-391.
[10]	Samimi DB， Alabiad CR， Tse DT. An anatomically based approach to intralesional corticosteroid injection for eyelid capillary hemangiomas. Ophthalmic Surg Lasers Imaging，2012， 43：190-195.
[11]	Schwartz SR， Kodsi SR， Blei F， et al. Treatment of capillary hemangiomas causing refractive and occlusional amblyopia. J AAPOS，2007，11：577-583.
[12]	Arneja JS， Mulliken JB. Resection of amblyogenic periocular hemangiomas： indications and outcomes. Plast Reconstr Surg，2010，125：274-281.
[13]	Fabian ID， Ben-Zion I， Samuel C， et al. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. Am J Ophthalmol，2011，151：53-58.
[14]	Leaute-Labreze C， Dumas de la Roque E， Hubiche T， et al. Propranolol for severe hemangiomas of infancy. N Engl J Med，2008，358：2649-2651.
[15]	Al Dhaybi R， Superstein R， Milet A， et al. Treatment of periocular infantile hemangiomas with propranolol： case series of 18 children. Ophthalmology，2011，118：1184-1188.
[16]	Snir M， Reich U， Siegel R， et al. Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye （Lond），2011，25：1627-3164.
[17]	Hadaschik E， Scheiba N， Engstner M， et al. High levels of beta2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol. J Cutan Pathol，2012，39：881-883.
[18]	Chim H， Armijo BS， Miller E， et al. Propranolol induces regression of hemangioma cells through HIF-1alpha-mediated inhibition of VEGF-A. Ann Surg，2012，256：146-156.
[19]	Wong A， Hardy KL， Kitajewski AM， et al. Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg，2012，130：1012-1021.
[20]	Ji Y， Li K， Xiao X， et al. Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. J Pediatr Surg，2012，47（12）：2216-2223.
[21]	Talaat AA， Elbasiouny MS， Elgendy DS， et al. Propranolol treatment of infantile hemangioma： clinical and radiologic evaluations. J Pediatr Surg，2012，47：707-714.
[22]	de Graaf M， Breur JM， Raphael MF， et al. Adverse effects of propranolol when used in the treatment of hemangiomas： a case series of 28 infants. J Am Acad Dermatol，2011，65：320-327.
[23]	Lawley LP， Siegfried E， Todd JL. Propranolol treatment for hemangioma of infancy： risks and recommendations. Pediatr Dermatol，2009，26：610-614.
[24]	Maturo S， Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol，2010，74：323-325.
[25]	Vassallo P， Forte R， Di Mezza A， et al. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol. Am J Ophthalmol，2013，155：165-170.
[26]	Haider KM， Plager DA， Neely DE， et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS，2010，14：251-256.
[27]	Sans V， de la Roque ED， Berge J， et al. Propranolol for severe infantile hemangiomas： follow-up report. Pediatrics，2009，124：423-431.
[28]	Xu SQ， Jia RB， Zhang W， et al. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma： an evidence-based systematic review. World J Pediatr，2013，9：221-229.
[29]	Spiteri Cornish K， Reddy AR. The use of propranolol in the management of periocular capillary haemangioma—a systematic review. Eye （Lond），2011，25：1277-1283.
[30]	Taban M， Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology，2010，117：195-195. e4.
[31]	Frank RC， Cowan BJ， Harrop AR， et al. Visual development in infants： visual complications of periocular haemangiomas. J Plast Reconstr Aesthet Surg，2010，63：1-8.
[32]	Mishra A， Holmes WJ， Gorst C， et al. Role of propranolol in the management of periocular hemangiomas. Plast Reconstr Surg，2010，126：671.
[33]	Ezekowitz RA， Mulliken JB， Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med，1992，326：1456-1463.
[34]	Batta K， Goodyear HM， Moss C， et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas： results of a 1-year analysis. Lancet，2002，360：521-527.
[35]	Hunzeker CM， Geronemus RG. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatol Surg，2010，36：590-597.